文献速递贫血与红细胞疾病

骨源性C端FGF23裂解肽在急性炎症中增加铁可利用性

Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation.
PubMed 文献 · Blood · 2023-01-01

急性炎症时骨细胞分泌C端FGF23裂解肽(Cter-FGF23),通过结合BMP2/BMP9抑制肝脏铁调素表达,从而增加循环铁。骨细胞特异性敲除Fgf23或Furin的小鼠在炎症时Cter-FGF23减少,铁调素过多致循环铁进一步降低;补充Cter-FGF23可降低铁调素并恢复正常血清铁。

要点

  • 骨细胞是急性炎症时Cter-FGF23的主要来源
  • Cter-FGF23通过结合BMP2/BMP9抑制铁调素产生
  • 骨细胞Fgf23或Furin缺失加重炎症所致低铁血症

核心结论

  • 急性炎症时骨是Cter-FGF23的主要来源,Cter-FGF23不依赖完整FGF23而通过减少BMP诱导的肝脏铁调素分泌来增加循环铁。

研究设计与样本

  • 小鼠实验研究,使用骨细胞特异性Fgf23敲除小鼠、骨细胞特异性Furin敲除小鼠、Fgf23敲除小鼠及野生型小鼠,观察急性炎症下Cter-FGF23对铁调素和铁代谢的调控。

主要发现

  • 骨细胞特异性敲除Fgf23的小鼠在急性炎症时Cter-FGF23水平降低约90%,并因铁调素产生过多导致循环铁进一步降低。
  • 骨细胞特异性敲除Furin致FGF23裂解受损的小鼠也出现类似结果。
  • Cter-FGF23肽可结合BMP家族成员BMP2和BMP9,二者均为已确定的铁调素诱导因子。
  • 同时给予Cter-FGF23与BMP2或BMP9可阻止BMP2/9诱导的Hamp信使RNA和循环铁调素水平升高,使血清铁恢复正常。
  • 在炎症Fgf23敲除小鼠中注射Cter-FGF23,以及在野生型小鼠中遗传性过表达Cter-Fgf23,均导致铁调素降低和循环铁水平升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inflammation leads to functional iron deficiency by increasing the expression of the hepatic iron regulatory peptide hepcidin. Inflammation also stimulates fibroblast growth factor 23 (FGF23) production by increasing both Fgf23 transcription and FGF23 cleavage, which paradoxically leads to excess in C-terminal FGF23 peptides (Cter-FGF23), rather than intact FGF23 (iFGF23) hormone. We determined that the major source of Cter-FGF23 is osteocytes and investigated whether Cter-FGF23 peptides play a direct role in the regulation of hepcidin and iron metabolism in response to acute inflammation. Mice harboring an osteocyte-specific deletion of Fgf23 showed a ∼90% reduction in Cter-FGF23 levels during acute inflammation. Reduction in Cter-FGF23 led to a further decrease in circulating iron in inflamed mice owing to excessive hepcidin production. We observed similar results in mice showing impaired FGF23 cleavage owing to osteocyte-specific deletion of Furin. We next showed that Cter-FGF23 peptides bind members of the bone morphogenetic protein (BMP) family, BMP2 and BMP9, which are established inducers of hepcidin. Coadministration of Cter-FGF23 and BMP2 or BMP9 prevented the increase in Hamp messenger RNA and circulating hepcidin levels induced by BMP2/9, resulting in normal serum iron levels. Finally, injection of Cter-FGF23 in inflamed Fgf23KO mice and genetic overexpression of Cter-Fgf23 in wild type mice also resulted in lower hepcidin and higher circulating iron levels. In conclusion, during inflammation, bone is the major source of Cter-FGF23 secretion, and independently of iFGF23, Cter-FGF23 reduces BMP-induced hepcidin secretion in the liver.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Courbon G, Thomas JJ, Martinez-Calle M, et al. Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation. Blood. 2023. PMID: 37053547. doi:10.1182/blood.2022018475

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。